Status
Conditions
Treatments
About
Due to global demographic changes, a notable trend of population aging has emerged, resulting in an increased prevalence of health conditions typically associated with the elderly. One such condition is cognitive impairment-dementia syndrome. Currently, 40,000 cases of dementia are registered in Lithuania (Health Information Centre), with projections estimating 81,000 cases by 2050 [13].
The care of individuals with dementia syndrome requires a holistic approach, incorporating both pharmacological and non-pharmacological interventions. The effectiveness of pharmacological treatment is limited: no highly effective drugs currently exist for Alzheimer's disease (available drugs have limited pathogenetic and symptomatic effects), there are no specific treatments for other forms of dementia, and the long-term use of medications to manage behavioral symptoms is associated with adverse effects. The OECD equates the routine use of neuroleptics with poor quality care [2]. Furthermore, even when medications are prescribed, non-pharmacological interventions should be applied concurrently [5].
One recommended method is arts therapy. Art therapy is a recognized psychosocial treatment that improves attention, perception, memory, and mood in people with dementia. However, there is a lack of studies evaluating the effectiveness of art therapy specifically in improving the psycho-emotional state of individuals with dementia syndrome.
Pharmacological treatments commonly used for dementia syndrome offer limited long-term benefits [23]. As the number of individuals affected by dementia continues to grow, increasing attention is being paid to improving their quality of life, social integration, and emotional well-being through non-pharmacological means. International guidelines recommend creative and artistic activities tailored to individual preferences, skills, and abilities, including music and dance [19]. One of the increasingly recognized interventions is art therapy [5]. Systematic review findings support the inclusion of various psychological interventions in the treatment of individuals with dementia who suffer from depression and/or anxiety disorders [3].
Globally, research most commonly explores the impact of art therapy on cognitive functions, quality of life, behavior, and psychological well-being in individuals with dementia [3; 4]. However, the FEATS scale is rarely used to assess emotional state changes. Although psycho-emotional issues are highly relevant and widely studied, relatively few studies explore these within the context of art therapy. Most existing research is qualitative, with a lack of quantitative studies.
The novelty of this planned study lies not only in the specificity of the participants but also in the application of the FEATS scale. While FEATS is widely used in research, few studies apply this instrument to explore the psycho-emotional state of people with dementia syndrome. The scale's authors and other researchers recommend expanding its use across diverse populations to assess its validity for different patient groups [10; 21].
This study will help reveal the effectiveness of art therapy as a non-invasive and non-pharmacological intervention for improving the psycho-emotional state of individuals with dementia syndrome. The research findings will contribute positively to patient well-being and the advancement of nursing science. Art therapy sessions are expected to improve participants' emotional state and reduce signs of anxiety, depression, and stress. This will provide scientific evidence of the effectiveness of art therapy and allow for the validation of the FEATS scale for assessing the psycho-emotional state of people with dementia syndrome.
Full description
Research Aim To determine changes in the psycho-emotional state of individuals with dementia syndrome through the application of art therapy.
Research Objectives
Instruments
Sample Size and Justification:
71 participants. The sample size was calculated based on 2022 data from the Lithuanian Health Information Centre.
Study Design and Stages
The following data will be collected from medical records:
The interventions used in this study are not listed in the Lithuanian Ministry of Health's Order No. V-1483 of December 31, 2014, which defines biomedical research methods causing minor and temporary adverse effects on participant health.
Planned Duration and Frequency of Visits Groups of 5-6 participants will meet twice a week for seven weeks.
Selection of Study Participants and Instruments Used To select study participants, the Mini-Mental State Examination (MMSE); [7] will be used-a short, quick, and easy-to-administer tool that quantitatively assesses cognitive functions [7; 16]. This instrument is widely used in clinical practice and scientific research. Its sensitivity ranges from 0.71 to 0.87 and specificity from 0.81 to 0.96 [15; 1].
The MMSE consists of 11 questions and tasks that analyze seven cognitive domains: orientation in time and space, memorization of three words, attention and calculation, recall of three words, language, and ability to follow simple verbal and written commands. The administration takes approximately 5-10 minutes. For each correct answer or correctly completed task, points are awarded. The fewer the points scored, the more severe the cognitive impairment. The maximum score is 30. A score of ≥25 indicates no cognitive impairment, 20-24 indicates mild impairment, 11-19 indicates moderate impairment, and 0-10 indicates severe cognitive impairment [1].
To assess the psycho-emotional state of the participants, two instruments will be used: the DASS-21 and the FEATS scales, each measuring psycho-emotional states through different approaches.
All instruments are valid, freely available, and do not require author permission for use.
To conduct the study, the following data will be collected:
The study will be conducted at the Nursing Clinic of Kaunas Clinics of Lithuanian University of Helth Sciences and the Kazys Grinius Nursing and Supportive Treatment Hospital. These institutions were chosen due to enough participants from the target group and because the length of stay of dementia patients allows for the implementation of the planned art therapy intervention.
Field Notes During and after the art therapy sessions, field notes will be kept documenting the study process. These notes will include the researcher's observations, thoughts, questions, and any changes in participants' health status.
Withdrawal from the Study Participants may voluntarily withdraw from the study at any time. No written request will be required. Participation will also be suspended if the researcher or medical staff observes any deterioration in the participant's health.
Recruitment Process The researcher will personally invite patients being treated in the departments and will also work with department staff. Additionally, an invitation poster will be displayed in the department, including the researcher's contact number for those interested.
Informed Consent Procedures Patients at the study sites will receive educational information about art therapy and its potential benefits. Those wishing to participate will be asked to sign an informed consent form. Before beginning, patients whose MMSE score is ≥11 (indicating no severe cognitive impairment) and who are not suffering from unstable chronic somatic illnesses will be selected. Participants must speak Lithuanian to engage in therapy reflections. Individuals meeting these criteria will be invited to participate. Each participant will be informed about the study process, session schedule, and duration.
Potential Benefits Art therapy sessions are expected to evoke positive emotions in participants. They may experience satisfaction, relaxation, and opportunities to form bonds with other group members. This is expected to improve their psycho-emotional state and reduce symptoms of depression, anxiety, and stress.
Potential Risks and Inconveniences Participants may perceive filling out sociodemographic questionnaires and attending art therapy sessions as time-consuming. Traveling to the study site may disrupt daily routines. Sharing personal experiences during therapy reflections may also cause emotional discomfort.
Documentation and Evaluation of Adverse Events
An adverse event is defined as:
Data Protection and Confidentiality
The collected data include:
All data will be pseudonymized using letter and number codes. If necessary, identifiable data will only be accessible to authorized monitors, ethics committees, or supervising institutions. Coded health data will be available only to the main researchers. Paper questionnaires will be assigned four-digit codes, stored in locked cabinets at the study site, and data will be entered into a OneDrive folder provided by the university and analyzed using SPSS. Access will be password-protected and known only to researchers.
Paper forms, DASS-21 data, and drawings will be stored for 10 years post-study for academic or ethical review, retrospective studies, or dispute prevention. Original data will be destroyed following institutional policy.
If needed, data may be shared with authorized persons, ethics committees, or other supervising institutions. Drawings created during therapy will be returned to participants or their relatives upon request.
De-identified data (study results) will be used in scientific publications and conference presentations.
Participants may withdraw consent at any time before the anonymization of their data. Identifiable data linking participants to their codes will be destroyed immediately after the study ends.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
71 participants in 1 patient group
Loading...
Central trial contact
Aušra Sebeikaitė, master; Jūratė Macijauskienė, professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal